
Full profile: /officials/G000583
Source: Congress.gov · FEC
Members who have signed on to support this bill since introduction. Source: Congress.gov.
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Currently in
Previously
Leo's Law This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period.
Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.
Bills by the same sponsor or covering overlapping subjects.